These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 1408191)
1. Genetic alterations in head and neck cancer. Somers KD; Schechter GL Otolaryngol Clin North Am; 1992 Oct; 25(5):1065-71. PubMed ID: 1408191 [TBL] [Abstract][Full Text] [Related]
2. Applications of molecular epidemiology to head and neck cancer. Hart TC Otolaryngol Clin North Am; 1997 Feb; 30(1):21-34. PubMed ID: 8995134 [TBL] [Abstract][Full Text] [Related]
3. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis. Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206 [TBL] [Abstract][Full Text] [Related]
4. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570 [TBL] [Abstract][Full Text] [Related]
5. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer. Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074 [TBL] [Abstract][Full Text] [Related]
6. Oncogenes related to head and neck cancer. Issing WJ; Wustrow TP; Heppt WJ Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494 [TBL] [Abstract][Full Text] [Related]
7. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck. Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018 [TBL] [Abstract][Full Text] [Related]
8. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592 [TBL] [Abstract][Full Text] [Related]
9. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Field JK Eur J Cancer B Oral Oncol; 1992 Jul; 28B(1):67-76. PubMed ID: 1330149 [TBL] [Abstract][Full Text] [Related]
10. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV. Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388 [TBL] [Abstract][Full Text] [Related]
11. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Somers KD; Cartwright SL; Schechter GL Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294 [TBL] [Abstract][Full Text] [Related]
12. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma. Ferris RL; Grandis JR Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953 [No Abstract] [Full Text] [Related]
13. Overexpression of the p53 gene in primary and metastatic head and neck carcinomas. Sauter ER; Ridge JA; Trock B; Cleveland D; Whitley KV; Mohr RM; Klein-Szanto A Laryngoscope; 1995 Jun; 105(6):653-6. PubMed ID: 7769953 [TBL] [Abstract][Full Text] [Related]
14. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death. Frederick MJ; Holton PR; Hudson M; Wang M; Clayman GL Clin Cancer Res; 1999 Feb; 5(2):361-9. PubMed ID: 10037186 [TBL] [Abstract][Full Text] [Related]
15. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck. Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551 [TBL] [Abstract][Full Text] [Related]
16. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Akervall JA; Michalides RJ; Mineta H; Balm A; Borg A; Dictor MR; Jin Y; Loftus B; Mertens F; Wennerberg JP Cancer; 1997 Jan; 79(2):380-9. PubMed ID: 9010112 [TBL] [Abstract][Full Text] [Related]
17. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Patel AM; Incognito LS; Schechter GL; Wasilenko WJ; Somers KD Oncogene; 1996 Jan; 12(1):31-5. PubMed ID: 8552396 [TBL] [Abstract][Full Text] [Related]
18. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. Frank DK; Liu TJ; Frederick MJ; Clayman GL Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148 [TBL] [Abstract][Full Text] [Related]
19. Variability of genetic alterations in different sites of head and neck cancer. Rodrigo JP; Suárez C; González MV; Lazo PS; Ramos S; Coto E; Alvarez I; García LA; Martínez JA Laryngoscope; 2001 Jul; 111(7):1297-301. PubMed ID: 11568558 [TBL] [Abstract][Full Text] [Related]
20. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]